SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Aspira Women's Health Inc.
Date: Jan. 6, 2026 · CIK: 0000926617 · Accession: 0000000000-26-000098

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292512

Date
January 6, 2026
Author
Michael Buhle
Form
UPLOAD
Company
Aspira Women's Health Inc.

Letter

January 6, 2026 Michael Buhle Chief Executive Officer Aspira Women's Health Inc. 12117 Bee Caves Road, Building III, Suite 100 Austin, TX 78738 Re:Aspira Women's Health Inc. Registration Statement on Form S-1 Filed December 31, 2025 File No. 333-292512 Dear Michael Buhle: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:J. Eric Johnson, Esq.

Show Raw Text
January 6, 2026
Michael Buhle
Chief Executive Officer
Aspira Women's Health Inc.
12117 Bee Caves Road, Building III, Suite 100
Austin, TX 78738
Re:Aspira Women's Health Inc.
Registration Statement on Form S-1
Filed December 31, 2025
File No. 333-292512
Dear Michael Buhle:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:J. Eric Johnson, Esq.